NFKB1 and diffuse large B-cell lymphoma: Nonetheless, whether ACTB is engaged in the activation or inhibition of the necroptosis pathway in DLBCL by influencing RIPK1-mediated changes in the NF-κB pathway has not yet been investigated, and this is a direction worth exploring.